Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Comparing Perception of Antonymy Between Persian-Speaking Educable Children With Intellectual Disabilities and Typically Developing Children. BCN. 2017;
This article has no abstract.
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2018/05/16 | Accepted: 2018/05/16 | Published: 2018/05/16

1. Moschino L, Zanconato S, Bozzetto S, Baraldi E, Carraro S. Childhood asthma biomarkers: present knowledge and future steps. Paediatric respiratory reviews. 2015;16(4):205-12. [DOI:10.1016/j.prrv.2015.05.001] [PMID]
2. Ghaffari J, Aarabi M. The prevalence of pediatric asthma in the Islamic Republic of Iran: A review and meta-analysis, J Pediatr Rev. 2013;1(1):2-12.
3. Gibeon D, Menzies-Gow AN. Targeting interleukins to treat severe asthma. Expert review of respiratory medicine. 2012;6(4):423-39. [DOI:10.1586/ers.12.38] [PMID]
4. Zedan MM, Osman AM, Laimon WN, Abo-elkheir NY, Zaki A. Airway Inflammatory Biomarker:Could It Tailor the Right Medications for the Right Asthmatic Patient? Iranian journal of immunology : IJI. 2016;13(2):70-88. [PMID]
5. Fainardi V, Saglani S. The need to differentiate between adults and children when treating severe asthma. Expert review of respiratory medicine. 2015;9(4):419-28. [DOI:10.1586/17476348.2015.1068693] [PMID]
6. Bush A, Menzies-Gow A. Phenotypic differences between pediatric and adult asthma. Proceedings of the American Thoracic Society. 2009;6(8):712-9. [DOI:10.1513/pats.200906-046DP] [PMID]
7. Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in children. The journal of allergy and clinical immunology In practice. 2014;2(5):489-500. [DOI:10.1016/j.jaip.2014.06.022] [PMID] [PMCID]
8. Federico MJ, Hoch HE, Anderson WC, Spahn JD, Szefler SJ. Asthma Management for Children. Advances in Pediatrics. 2016;63:103-26. [DOI:10.1016/j.yapd.2016.04.010] [PMID]
9. Chelbi H, Ghadiri A, Lachheb J, Ghandil P, Hamzaoui K, Hamzaoui A, et al. A polymorphism in the CCL2 chemokine gene is associated with asthma risk: a case–control and a family study in Tunisia. Genes and Immunity. 2008 9:575–81. [DOI:10.1038/gene.2008.50] [PMID]
10. Wilson N, James A, Uasuf C, Payne DN, Hablas H, Agrofioti C, et al. Asthma severity and infammation markers in children. Pediatr Allergy Immunol. 2001;12:125-32. [DOI:10.1034/j.1399-3038.2001.012003125.x] [PMID]
11. Brown V, Warke TJ, Shields MD, Ennis M. T cell cytokine profiles in childhood asthma. Thorax. 2003;58(4):311-6. [DOI:10.1136/thorax.58.4.311] [PMID] [PMCID]
12. Bossley CJ, Fleming L, Gupta A, Regamey N, Frith J, Oates T, et al. Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines. The Journal of allergy and clinical immunology. 2012;129(4):974-82.e13. [DOI:10.1016/j.jaci.2012.01.059] [PMID] [PMCID]
13. LEUNG TF, Wong GW. Noninvasive Monitoring of Airway Inflammation in Childhood Asthma. HK J Paediatr. 2007;12:38-41.
14. Mahajan S, Mehta AA. Role of Cytokines in Pathophysiology of Asthma. Iranian Journal Of Pharmacology & Therapeutics. 2006; 5:1-14.
15. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. The Journal of allergy and clinical immunology. 2006;117(2):269-74. [DOI:10.1016/j.jaci.2005.10.024] [PMID]
16. Koloskova E, Bezrukov L, Marusyk U, Lobanova T, Burenyuk C. Markers of Atopic Reactivity In The Puplis With Severe Bronchial Asthma. Medicine and Dentistry. 2016;3.
17. Shahid SK, Kharitonov SA, Wilson NM, Andrew Bush A, Barnes PJ. Increased Interleukin-4 and Decreased Interferon-ᵧ in Exhaled Breath Condensate of Children with Asthma. American journal of respiratory and critical care medicine. 2002;165:1290-3. [DOI:10.1164/rccm.2108082] [PMID]
18. Hussein YM, Alzahrani SS, Alharthi AA, Ghonaim MM, Alhazmi AS, Eed EM, et al. Association of serum cytokines levels, interleukin 10 -1082G/A and interferon-gamma +874T/A polymorphisms with atopic asthma children from Saudi Arabia. Cellular immunology. 2014;289(1-2):21-6. [DOI:10.1016/j.cellimm.2014.03.006] [PMID]
19. Keskin O, Keskin M, Kucukosmanoglu E, Ozkars MY, Gogebakan B, Kul S, et al. Exhaled RANTES and interleukin 4 levels after exercise challenge in children with asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2012;109(5):303-8. [DOI:10.1016/j.anai.2012.08.009] [PMID]
20. Al-Daghri NM, Alokail MS, Draz HM, Abd-Alrahman SH, Yakout SM, Clerici M. Th1/Th2 cytokine pattern in Arab children with severe asthma. International journal of clinical and experimental medicine. 2014;7(8):2286-91. [PMID] [PMCID]
21. Bush A. Problematic, severe asthma in children: a new concept and how to manage it. Acta Medica Lituanica. 2010;17(1):51-64. [DOI:10.2478/v10140-010-0007-7]
22. Machura E, Mazur B, Rusek-Zychma M, Barc-Czarnecka M. Cytokine production by peripheral blood CD4+ and CD8+ T cells in atopic childhood asthma. Clinical & developmental immunology. 2010;2010:606139. [DOI:10.1155/2010/606139] [PMID] [PMCID]
23. Zagorska W, Grzela K, Kulus M, Sobczynski M, Grzela T. Nitric oxide, IL-6 and IL-13 are increased in the exhaled breath condensates of children with allergic rhinitis. Acta paediatrica (Oslo, Norway : 1992). 2014;103(4):e148-53.
24. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. The Journal of allergy and clinical immunology. 2003;111(2):227-42; quiz 43. [DOI:10.1067/mai.2003.139] [PMID]
25. Fitzpatrick AM, Higgins M, Holguin F, Brown LA, Teague WG. The molecular phenotype of severe asthma in children. The Journal of allergy and clinical immunology. 2010;125(4):851-7.e18. [DOI:10.1016/j.jaci.2010.01.048] [PMID] [PMCID]
26. Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, et al. Increased sputum and bronchial biopsy IL-13 expression in severe asthma. The Journal of allergy and clinical immunology. 2008;121(3):685-91. [DOI:10.1016/j.jaci.2008.01.005] [PMID] [PMCID]
27. Papathanassiou E, Loukides S, Bakakos P. Severe asthma: anti-IgE or anti-IL-5? European clinical respiratory journal. 2016;3:31813.
28. Sulaiman I, Lim JC, Soo HL, Stanslas J. Molecularly targeted therapies for asthma: Current development, challenges and potential clinical translation. Pulmonary pharmacology & therapeutics. 2016;40:52-68. [DOI:10.1016/j.pupt.2016.07.005] [PMID]
29. Anderson WC, Szefler SJ. New and future strategies to improve asthma control in children. The Journal of allergy and clinical immunology. 2015;136(4). [DOI:10.1016/j.jaci.2015.07.007]
30. Tateno H, Nakamura H, Minematsu N, Nakajima T, Takahashi S, Nakamura M, et al. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respiratory medicine. 2004;98(8):782-90. [DOI:10.1016/j.rmed.2004.01.005] [PMID]
31. Morishima Y, Ano S, Ishii Y, Ohtsuka S, Matsuyama M, Kawaguchi M, et al. Th17-Associated Cytokines as a Therapeutic Target for Steroid-Insensitive Asthma. Clinical and Developmental Immunology. 2013. [DOI:10.1155/2013/609395] [PMID] [PMCID]
32. Zeng R, Li C, Li N, Wei L, Cui Y. The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine. 2011;53(1):1-7. [DOI:10.1016/j.cyto.2010.09.011] [PMID]
33. Alyasin S, Karimi MH, Amin R, Babaei M, Darougar S. Interleukin-17 Gene Expression and Serum Levels in Children with Severe Asthma. Iranian journal of immunology : IJI. 2013;10(3):179-87.
34. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. The Journal of allergy and clinical immunology. 2003;111(6):1293-8. [DOI:10.1067/mai.2003.1557] [PMID]
35. Padrón-Morales J, García-Solaesa V, Isidoro-García M, Hernández-Hernández L, García-Sánchez A, Hincapié-López G, et al. Implications of cytokine genes in allergic asthma. Allergol Immunopathol. 2014. [DOI:10.1016/j.aller.2013.11.006] [PMID]
36. Ghaffari J, Rafiei AR, Ajami A, Mahdavi M, Hoshiar B.Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference? Caspian J Intern Med. 2011 Spring;2(2):226-8. [PMID] [PMCID]
37. Al-Alawi M, Tidi Hassan T, Chotirmall SH. Transforming growth factor b and severe asthma: A perfect storm. Respiratory medicine. 2014;108:1409-23. [DOI:10.1016/j.rmed.2014.08.008] [PMID]
38. Raby BA, Van Steen K, Lazarus R, Celedon JC, Silverman EK, Weiss ST. Eotaxin polymorphisms and serum total IgE levels in children with asthma. The Journal of allergy and clinical immunology. 2006;117(2):298-305. [DOI:10.1016/j.jaci.2005.10.041] [PMID]
39. Mpharm AVC, Hemalatha R, Murali MV, Jayaprakash D, Dinesh Kumar B. Association of T-regulatory cells and CD23/CD21 expression with vitamin D in children with asthma. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2016:447-54.
40. Brown SD, Baxter KM, Stephenson ST, Esper AM, Brown LA, Fitzpatrick AM. Airway TGF-beta1 and oxidant stress in children with severe asthma: association with airflow limitation. The Journal of allergy and clinical immunology. 2012;129(2):388-96, 96.e1-8.
41. El-Sayed ZA, El-Hakim IZ, El-Kerdani TA, Ghanem HM. Serum transforming growth factor-beta1 in asthmatic children. Egypt J Pediatr Allergy Immunol. 2004;2(1):46-51.
42. Sharma S, Raby BA, Hunninghake GM, Soto-Quiros M, Avila L, Murphy AJ, et al. Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. American journal of respiratory and critical care medicine. 2009;179(5):356-62. [DOI:10.1164/rccm.200808-1268OC] [PMID] [PMCID]
43. Konradsen JR, Nordlund B, Levanen B, Hedlin G, Linden A. The cytokine interleukin-26 as a biomarker in pediatric asthma. Respiratory research. 2016;17:32. [DOI:10.1186/s12931-016-0351-6] [PMID] [PMCID]
44. Kato M, Suzuki K, Yamada Y, Maruyama K, Hayashi Y, Mochizuki H. Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma. Allergology international : official journal of the Japanese Society of Allergology. 2015;64 Suppl:S64-70.
45. Machura E, Szczepanska M, Mazur B, Chrobak E, Ziora K, Ziora D, et al. Selected CC and CXC chemokines in children with atopic asthma. Postepy dermatologii i alergologii. 2016;33(2):96-101. [DOI:10.5114/ada.2016.59150]
46. Parulekar AD, Diamant Z, Hanania NA. Role of T2 inflammation biomarkers in severe asthma. Current opinion in pulmonary medicine. 2016;22(1):59-68. [DOI:10.1097/MCP.0000000000000231] [PMID]
47. Grzela K, Litwiniuk M, Krejner A, Zagorska W, Grzela T. Increased angiogenic factors in exhaled breath condensate of children with severe asthma - New markers of disease progression? Respiratory medicine. 2016;118:119-21. [DOI:10.1016/j.rmed.2016.08.005] [PMID]
48. Leung TF, Wong GW, Ko FW, Li CY, Yung E, Lam CW, et al. Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children. International archives of allergy and immunology. 2005;137(1):66-72. [DOI:10.1159/000085106] [PMID]
49. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nature reviews Immunology. 2001;1(2):108-16. [DOI:10.1038/35100503] [PMID]
50. Leung TF, Wong CK, Lam CW, Li AM, Ip WK, Wong GW, et al. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. The European respiratory journal. 2003;21(4):616-20. [DOI:10.1183/09031936.03.00083303] [PMID]
51. Hartl D, Griese M, Nicolai T, Zissel G, Prell C, Konstantopoulos N, et al. Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. The Journal of allergy and clinical immunology. 2005;115(4):728-36. [DOI:10.1016/j.jaci.2004.11.049] [PMID]
52. Saad-El-Din Bessa S, Abo El-Magd GH, Mabrouk MM. Serum chemokines RANTES and monocyte chemoattractant protein-1 in Egyptian patients with atopic asthma: relationship to disease severity. Archives of medical research. 2012;43(1):36-41. [DOI:10.1016/j.arcmed.2012.01.009] [PMID]
53. Huang H, Nie W, Zang Y, Chen J, Xiu Q. Association between CC motif chemokine ligand 5 (CCL5) polymorphisms and asthma risk: an updated meta-analysis. Journal of investigational allergology & clinical immunology. 2015;25(1):26-33. [PMID]
54. El-Gamal Y, El-Awady HM, El-Halim AA, Abd-Allah E. ِIncreased expression of T- cell- surface CXCR4 in asthmatic children. Egypt J Pediatr Allergy Immunol. 2003;1(2):80-5.
55. Carr TF, Berdnikovs S, Simon H, Bochner BS, Rosenwasser LJ. Eosinophilic bioactivities in severe asthma. World Allergy Organization Journal 2016;9(21). [DOI:10.1186/s40413-016-0112-5]
56. El-Gamal YM, Ezzat MH, Awwad KS, Heshmat NM, Abd AlAziz MM, ElGabbas ZM. Monocyte chemotactic protein-4 (MCP-4/CCL-13) and CC chemokine receptor 3 (CCR3) in the sputum of asthmatic children. Egypt J Pediatr Allergy Immunol. 2008;6(1):13-25.
57. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. The Journal of allergy and clinical immunology. 2004;113(3):482-8. [DOI:10.1016/j.jaci.2003.12.374] [PMID]
58. Saglani S, Lloyd CM. Eosinophils in the pathogenesis of paediatric severe asthma. Current opinion in allergy and clinical immunology. 2014;14(2):143-8. [DOI:10.1097/ACI.0000000000000045] [PMID]
59. Barreto M, Zambardi R, Villa MP. Exhaled nitric oxide and other exhaled biomarkers in bronchial challenge with exercise in asthmatic children: current knowledge. Paediatric respiratory reviews. 2015;16(1):68-74. [DOI:10.1016/j.prrv.2013.11.006] [PMID]
60. Ullmann N, Bossley CJ, Fleming L, Silvestri M, Bush A, Saglani S. Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma. Allergy. 2013;68(3):402-6. [DOI:10.1111/all.12101] [PMID]
61. Katoa M, Yamadaa Y, Maruyamab K, Hayashic K. Serum Eosinophil Cationic Protein and 27 Cytokines/Chemokines in Acute Exacerbation of Childhood Asthma. International archives of allergy and immunology. 2010;152:62-6. [DOI:10.1159/000312127] [PMID]
62. Bossley C, Suri R. An Update on Pediatric Severe Asthma. Current Allergy & Clinical Immunology. 2013;26.
63. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. The Journal of allergy and clinical immunology. 2010;126(1):52-8.e5. [DOI:10.1016/j.jaci.2010.03.043] [PMID] [PMCID]
64. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. The Journal of allergy and clinical immunology. 2011;127(5):1294-6. [DOI:10.1016/j.jaci.2010.12.016] [PMID]
65. Hamzaoui A, Ammar J, Hamzaoui K. Regulatory T cells in induced sputum of asthmatic children: association with inflammatory cytokines. Multidisciplinary respiratory medicine. 2010;5(1):22-30. [DOI:10.1186/2049-6958-5-1-22] [PMID] [PMCID]
66. Hassannia H, Abediankenari S, Ghaffari J. FOXP3 and TGF-β Gene Polymorphisms in Allergic Rhinitis. Iran J Immunol. 2011 Dec;8(4):218-25. [PMID]
67. Papaioannou AI, Spathis A, Kostikas K, Karakitsos P, Papiris S, Rossios C. The role of endosomal toll-like receptors in asthma. European journal of pharmacology. 2016. [PMID]
68. Zakeri A, Yazdi FG. Toll-like receptor-mediated involvement of innate immune cells in asthma disease. Biochimica et biophysica acta. 2017;1861(1 Pt A):3270-7. [DOI:10.1016/j.bbagen.2016.08.009] [PMID]
69. Katsaounou P, Asimakos A, Barnes PJ. Non invasive assessment of severe asthma. Pneumon 2011;24(4).
70. Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, Koenderman L. Clinical utility of asthma biomarkers: from bench to bedside. Biologics : targets & therapy. 2013;7:199-210. [PMID] [PMCID]
71. Alessandra Chiappori A, Laura De Ferrari LD, Chiara Folli C, Pierluigi Mauri P, Riccio AM, Canonica GW. Biomarkers and severe asthma: a critical appraisal. Clin Mol Allergy. 2015;13(20). [PMID] [PMCID]
72. Kaza V, Bandi V, Guntupalli K. Acute severe asthma: recent advances. Current opinion in pulmonary medicine. 2007;13:1-7. [DOI:10.1097/MCP.0b013e328011a91c]
73. Matsunaga K, Yanagisawa S, Ichikawa T, Ueshima K, Keiichirou Akamatsu K, Tsunahiko Hirano T, et al. Airway cytokine expression measured by means of protein array in exhaled breath condensate: Correlation with physiologic properties in athmatic patients. The Journal of allergy and clinical immunology. 2006;118. [DOI:10.1016/j.jaci.2006.04.020]
74. Korevaar DA, Westerhof GA, Wang J, Cohen JF, Spijker R, Sterk PJ, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. The Lancet Respiratory medicine. 2015;3(4):290-300. [DOI:10.1016/S2213-2600(15)00050-8]
75. Meyer N, Nuss SJ, Rothe T, Siebenhuner A, Akdis CA, Menz G. Differential serum protein markers and the clinical severity of asthma. Journal of asthma and allergy. 2014;7:67-75. [DOI:10.2147/JAA.S53920] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
Write the security code in the box

© 2015 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb